ClinicalTrials.gg
Not yet recruitingNCT07948499Updated Nov 19, 2026

COMPARISON OF OUTCOME OF DORSAL EXTENDED SPREADER GRAFT WITH DICED CARTILAGE VERSUS BLOCK WITH DICED CARTILAGE IN RHINOPLASTY FOR SADDLE NOSE DEFORMITY

An interventional study of Dorsal Extended Spreader Graft With Diced Cartilage and Block Graft With Diced Cartilage in Nose Deformities, Acquired and Nose Deformity, sponsored by King Edward Medical University. Not yet recruiting. Open to participants aged 13 Years to 49 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by King Edward Medical University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
13 Years to 49 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare two surgical techniques for treating saddle nose deformity during rhinoplasty. It will also assess patient satisfaction and postoperative complications. The main questions it aims to answer are:

  • Does a dorsal extended spreader graft with diced cartilage provide better aesthetic outcomes than a block graft with diced cartilage?
  • Is there a difference in patient satisfaction between the two techniques?
  • What complications occur after each surgical technique?

Participants will:

  • Undergo rhinoplasty using either a dorsal extended spreader graft with diced cartilage or a block graft with diced cartilage.
  • Attend postoperative follow-up visits at 1 week, 1 month, and 3 months.
  • Have their nasal appearance and aesthetic outcome assessed by surgeons.
  • Complete a patient satisfaction assessment using the Rhinoplasty Outcome Evaluation (ROE) score.
  • Be assessed for complications such as infection, bruising, hematoma, warping, and dorsal irregularities.
Read the detailed description

This clinical trial will evaluate two surgical techniques used for the correction of saddle nose deformity during rhinoplasty. Saddle nose deformity is characterized by loss of nasal dorsal height, commonly associated with collapse or inadequate support of the nasal septum. It can affect both the appearance and function of the nose, including nasal breathing.

The study will compare a dorsal extended spreader graft combined with diced cartilage with a block graft combined with diced cartilage. Both techniques use autologous costal cartilage. The dorsal extended spreader graft is intended to provide structural support and restore the nasal dorsum, while the diced cartilage is used as an onlay layer to improve contour and surface smoothness. In the block graft technique, a thin cartilage block provides structural support over the residual nasal septum, while diced cartilage is placed over it to achieve a smooth dorsal contour.

The study will assess the postoperative results of both techniques, particularly the improvement in nasal appearance, dorsal contour, dorsal height, nasal symmetry, tip projection and overall aesthetic harmony. Patient-perceived satisfaction will also be evaluated using the Rhinoplasty Outcome Evaluation score.

Postoperative complications will be monitored during follow-up. These will include infection, bruising, hematoma, warping, and dorsal irregularities. The outcomes of the two techniques will then be compared to determine whether one technique provides better aesthetic results, patient satisfaction, and postoperative outcomes in patients with saddle nose deformity.

02

Conditions studied

  • Nose Deformities, Acquired
  • Nose Deformity

Keywords

  • Saddle nose deformity
  • Rhinoplasty
03

In context

Lead sponsor

King Edward Medical University is the lead sponsor of 85 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 49 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients with saddle nose deformity (Type II-IV).
  2. Age 13-49 years
  3. Both male and female

Exclusion criteria

Exclusion Criteria:

  1. Recurrent cases
  2. Diabetic and hypertensive patients
  3. Patient with cleft nasal deformity
  4. Patient with facial asymmetry
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Dorsal Extended Spreader Graft With Diced Cartilage

    Participants in this arm will undergo rhinoplasty for saddle nose deformity using an autologous dorsal extended spreader graft with diced cartilage. Costal cartilage will be harvested and carved into an extended spreader graft, which will be placed bilaterally between the nasal septum and upper lateral cartilages to provide structural support. Diced cartilage will then be placed as an onlay layer to improve dorsal symmetry and contour.

    Procedure: Dorsal Extended Spreader Graft With Diced Cartilage

  • Active comparator
    Block Graft With Diced Cartilage

    Participants in this arm will undergo rhinoplasty for saddle nose deformity using an autologous block graft with diced cartilage. Costal cartilage will be shaped into a thin block and placed horizontally over the residual nasal septum, where it will be secured with sutures to provide structural support. Fine-diced cartilage will then be placed over the block graft to achieve a smooth and well-contoured nasal dorsum.

    Procedure: Block Graft With Diced Cartilage

Interventions

  • ProcedureDorsal Extended Spreader Graft With Diced Cartilage

    Autologous costal cartilage will be harvested and carved into an extended spreader graft. The graft will be placed bilaterally between the nasal septum and upper lateral cartilages and secured with sutures to provide structural support. Onlay diced cartilage will then be placed over the graft to improve nasal symmetry and achieve a smooth dorsal contour.

  • ProcedureBlock Graft With Diced Cartilage

    Autologous costal cartilage will be shaped into a thin block and placed horizontally over the residual nasal septum. The block graft will be secured with sutures to prevent displacement, followed by placement of fine-diced cartilage over the block to provide a smooth and well-contoured nasal dorsum.

06

What researchers measure

Primary outcomes

  1. Aesthetic Outcome at 3 Months

    Improvement in nasal aesthetics assessed at 3 months using the surgeon assessment score based on postoperative photographs.

    Time frame: 3 months

  2. Patient Satisfaction at 3 Months

    Assessed using the Rhinoplasty Outcome Evaluation (ROE) score.

    Time frame: 3 months

Secondary outcomes

  1. Postoperative Complications

    Assessment of infection, bruising, hematoma, warping, and dorsal irregularities.

    Time frame: 1 week and 3 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Hyun SM, Jang YJ. Treatment outcomes of saddle nose correction. JAMA Facial Plast Surg. 2013 Jul-Aug;15(4):280-6. doi: 10.1001/jamafacial.2013.84. PubMed 23681183 ↗

Individual participant data

Plan to share: No — Individual participant-level data will not be shared with other researchers. The study will maintain participant confidentiality and protect personal and clinical information. Study findings will be reported in aggregate form without identifying individual participants. Any sharing of study results will be limited to summarized, non-identifiable data.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2026
First posted
Nov 19, 2026
StartEst.
Nov 20, 2026
Primary completionEst.
Nov 20, 2027
CompletionEst.
Nov 20, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948499
Lead sponsor
King Edward Medical University
Responsible party
Farrukh Aslam (professor, King Edward Medical University) — Principal investigator
First posted
Nov 19, 2026
Start date
Nov 20, 2026 (estimated)
Primary completion
Nov 20, 2027 (estimated)
Completion
Nov 20, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Muhammad Rashid, MBBS, FCPS
Contact
m.rakhan121@gmail.com
+923450334330

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion